Floatz logo

LIDOCAINE

Neck Pain

Ankara UniversitySmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Neck Pain cohort.

Asset / SponsorPhaseRating
Amitryptiline
St Joseph University, Beirut, Lebanon
Phase 4BB
Xylocaine
Pain Management Center of Paducah
Phase 4BB
Celestone
Pain Management Center of Paducah
Phase 4BB
Triamcinalone
Northwestern University
Phase 4BB
Tizanidine
Stanford University
Phase 3B

View all 11 →

Same molecule, other indications

LIDOCAINE is also rated in:

peripheral neuropathyDormant
BBB
Indicative ·
79 / 100
View asset →
postherpetic neuralgiaDormant
BBB
Indicative ·
78 / 100
View asset →
post-operative pain, non-human animalDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →